Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diets and enteral supplements for improving outcomes in chronic kidney disease.
Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA. Kalantar-Zadeh K, et al. Among authors: raj ds. Nat Rev Nephrol. 2011 May 31;7(7):369-84. doi: 10.1038/nrneph.2011.60. Nat Rev Nephrol. 2011. PMID: 21629229 Free PMC article. Review.
Erratum to: Wasting in chronic kidney disease.
Mak RH, Ikizler TA, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Mak RH, et al. Among authors: raj ds. J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):119. doi: 10.1007/s13539-011-0026-6. J Cachexia Sarcopenia Muscle. 2011. PMID: 22477651 Free PMC article. No abstract available.
The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study.
Raj DS, Sohn MB, Charytan DM, Himmelfarb J, Ikizler TA, Mehrotra R, Ramezani A, Regunathan-Shenk R, Hsu JY, Landis JR, Li H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Raj DS, et al. Kidney360. 2021 Jan 15;2(3):445-455. doi: 10.34067/KID.0006132020. eCollection 2021 Mar 25. Kidney360. 2021. PMID: 35369018 Free PMC article.
Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial.
Charytan DM, Hsu JY, Mc Causland FR, Waikar SS, Ikizler TA, Raj DS, Landis JR, Mehrotra R, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Charytan DM, et al. Among authors: raj ds. Kidney360. 2020 Oct 15;1(12):1380-1389. doi: 10.34067/KID.0004342020. eCollection 2020 Dec 31. Kidney360. 2020. PMID: 35372900 Free PMC article. Clinical Trial.
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Charytan DM, et al. Among authors: raj ds. Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23. Kidney Int. 2019. PMID: 30473139 Free PMC article. Clinical Trial.
A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
Dember LM, Hung A, Mehrotra R, Hsu JY, Raj DS, Charytan DM, Mc Causland FR, Regunathan-Shenk R, Landis JR, Kimmel PL, Kliger AS, Himmelfarb J, Ikizler TA; Hemodialysis Novel Therapies Consortium. Dember LM, et al. Among authors: raj ds. Kidney Int. 2022 Nov;102(5):1178-1187. doi: 10.1016/j.kint.2022.06.022. Epub 2022 Jul 19. Kidney Int. 2022. PMID: 35863559 Free PMC article. Clinical Trial.
Amino acid repletion does not decrease muscle protein catabolism during hemodialysis.
Raj DS, Adeniyi O, Dominic EA, Boivin MA, McClelland S, Tzamaloukas AH, Morgan N, Gonzales L, Wolfe R, Ferrando A. Raj DS, et al. Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1534-42. doi: 10.1152/ajpendo.00599.2006. Epub 2007 Jan 30. Am J Physiol Endocrinol Metab. 2007. PMID: 17264222 Free article. Clinical Trial.
174 results